Biotech
WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwired) -- 11/01/13 -- Miraculins Inc. (TSX VENTURE: MOM), (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing di ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 11/01/13 -- AtmanCo Inc. ("AtmanCo " or the "Company ") (TSX VENTURE: ATW) is pleased to announce that two more organizations have decided to ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 10/31/13 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (ISIN: US74154B2034) ("Prima", the "Company") yesterday released its Appendix 4C - Qua ...
CARY, NC: CARY, NC -- (Marketwired) -- 10/31/13 -- Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today announced that it will host a conference call at 8:30 a.m. ET on Thursday, November 7, 2013, to discuss its ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 10/31/13 -- -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE)Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) today announced its financial resu ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 10/31/13 -- Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) announced today that Regen BioPharma Inc. (a subsidiary of BMSN) is initiating the production of clinical ...
FREDERICK, MD: RecoveryRx(R) Therapy Is Reducing Post-Surgical Pain and Drug Use in a Global Market of 234 Million Surgeries Annually ...
LYON, FRANCE: Second NDA From Eclat Portfolio Accepted for FDA Review Preclinical Studies With Medusa hGH XL Completed ...
EXTON, PA: Conference Call Scheduled for 9 a.m. Today ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 10/31/13 -- Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, today ann ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 10/30/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conferences:David Hung, M.D., president and chief executive off ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 10/30/13 -- Prana Biotechnology (ASX: PBT) (NASDAQ: PRAN),PBT2 Increases numbers of Neurons in the brainPBT2 increases numbers of Synapses in the brainPBT2 in ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 10/30/13 -- (OTCBB: REPCF)(CNSX: RP), a clinical stage biopharmaceutical company focused on the development of autologous cell therapies for regenerat ...
AURORA, ON: AURORA, ON -- (Marketwired) -- 10/29/13 -- Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 10/29/13 -- Trimel Pharmaceuticals Corporation (TSX: TRL) will report its third quarter financial results for the period ended September 30, 2013 on Sunday, Nove ...
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwired) -- 10/29/13 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced today that it is extending the expiry date of 12,500,000 common share purchase ...
NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 10/29/13 -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Catalyst Pharmaceutical Partners, Inc. ("Catalyst" or the ...
NEW YORK, NY: Phase III Program in Bronchiectasis Planned to Launch in 2014; Recent Partnership With Grifols Worth Up to $90 Million Plus Tiered Royalties; Report Available for Download at http://lifesciadvisors.co ...
CAVE CREEK, AZ: CAVE CREEK, AZ -- (Marketwired) -- 10/29/13 -- Endexx Corporation (OTC Pink: EDXC) reports that it has submitted the initial disclosure documents and the required legal opinion in preparation for rem ...
